AFIMMUNE LTD has a total of 69 patent applications. It increased the IP activity by 66.0%. Its first patent ever was published in 2013. It filed its patents most often in United States, Australia and China. Its main competitors in its focus markets pharmaceuticals, medical technology and organic fine chemistry are COGNITION PHARMACEUTICALS LLC, SEINFELD HUGO and RYTEK.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | Australia | 7 | |
#3 | China | 6 | |
#4 | EPO (European Patent Office) | 6 | |
#5 | Japan | 5 | |
#6 | Singapore | 5 | |
#7 | Israel | 4 | |
#8 | Mexico | 4 | |
#9 | Hong Kong | 3 | |
#10 | Republic of Korea | 3 | |
#11 | South Africa | 3 | |
#12 | Brazil | 2 | |
#13 | Canada | 2 | |
#14 | New Zealand | 2 | |
#15 | Russian Federation | 2 | |
#16 | Argentina | 1 | |
#17 | Philippines | 1 | |
#18 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Specific use of cosmetics | |
#4 | Electrotherapy |
# | Name | Total Patents |
---|---|---|
#1 | Climax John | 49 |
#2 | Coughlan David | 29 |
#3 | Duffy Kevin | 22 |
#4 | Rowe Jonathan | 18 |
#5 | John Climax | 14 |
#6 | Manku Mehar | 11 |
#7 | Kevin Duffy | 7 |
#8 | Jonathan Rowe | 7 |
#9 | David Coughlan | 6 |
#10 | Mehar Manku | 3 |
Publication | Filing date | Title |
---|---|---|
US2021085627A1 | Methods of treating diseases and disorders using compositions comprising 18-hepe, 12-hepe, or combinations thereof | |
WO2020229869A1 | Compositions comprising 15-hepe and/or 15-hetre and methods of treating or preventing cardiometabolic disease, metabolic syndrome, and/or related diseases | |
NZ744323A | Compositions comprising 15-hepe and methods of using the same | |
AU2015358512A1 | Compositions comprising 15-HEPE and methods of treating or preventing fibrosis using same | |
AU2015204531A1 | Pharmaceutical compositions comprising 15-HEPE and methods of treating asthma and lung disorders using same |